Pfizer Ltd

Pfizer Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Pfizer Ltd

₹ 5,037 1.16%
22 May 9:37 a.m.
pfizerindia.com BSE: 500680 NSE: PFIZER
About

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India.[1]
It is the 3rd largest multinational pharmaceutical company in India.[2]

Key Points

Parentage
The company is a subsidiary of Pfizer Inc. one of the world’s leading biopharma companies with a presence in over 125 countries. Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. [1] [2]

Website BSE NSE
  • Market Cap ₹ 23,044 Cr.
  • Current Price ₹ 5,037
  • High / Low ₹ 6,453 / 3,701
  • Stock P/E 36.0
  • Book Value ₹ 922
  • Dividend Yield 0.69 %
  • ROCE 21.6 %
  • ROE 16.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 59.6%

Cons

  • The company has delivered a poor sales growth of 1.18% over past five years.
  • Earnings include an other income of Rs.345 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
550 593 637 622 573 531 575 540 547 563 589 538 592
384 401 406 418 391 421 393 387 357 385 399 392 364
Operating Profit 165 192 232 203 182 111 183 153 189 177 189 146 228
OPM % 30% 32% 36% 33% 32% 21% 32% 28% 35% 32% 32% 27% 38%
17 -118 213 27 12 33 36 44 75 42 43 43 217
Interest 4 4 3 4 3 3 3 3 7 2 2 2 3
Depreciation 34 27 26 26 26 16 15 18 14 15 15 15 16
Profit before tax 145 43 415 201 165 126 201 176 244 203 215 172 426
Tax % 13% 25% 25% 25% 21% 26% 26% 26% 27% 26% 26% 26% 22%
126 33 311 151 130 94 149 130 179 151 158 128 331
EPS in Rs 27.50 7.12 68.00 32.93 28.34 20.44 32.56 28.41 39.10 32.94 34.61 27.89 72.34
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,112 1,853 2,012 1,966 1,969 2,082 2,152 2,239 2,611 2,425 2,193 2,281
872 1,438 1,579 1,616 1,468 1,516 1,578 1,526 1,775 1,616 1,555 1,541
Operating Profit 239 414 433 350 501 566 574 712 836 809 638 740
OPM % 22% 22% 22% 18% 25% 27% 27% 32% 32% 33% 29% 32%
109 44 97 232 114 167 183 81 63 134 185 345
Interest 1 2 1 2 1 2 11 15 11 13 15 8
Depreciation 8 250 58 63 66 71 103 109 115 106 62 61
Profit before tax 340 207 470 517 548 660 642 669 773 824 746 1,016
Tax % 35% 66% 35% 35% 34% 35% 21% 26% 21% 24% 26% 24%
221 70 305 337 360 429 509 498 613 624 551 768
EPS in Rs 74.01 15.26 66.67 73.62 78.71 93.79 111.29 108.77 133.90 136.38 120.52 167.79
Dividend Payout % 486% 82% 22% 27% 25% 24% 297% 32% 26% 51% 29% 98%
Compounded Sales Growth
10 Years: 2%
5 Years: 1%
3 Years: -4%
TTM: 4%
Compounded Profit Growth
10 Years: 20%
5 Years: 5%
3 Years: 2%
TTM: 17%
Stock Price CAGR
10 Years: 8%
5 Years: 4%
3 Years: 4%
1 Year: 11%
Return on Equity
10 Years: 16%
5 Years: 18%
3 Years: 17%
Last Year: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 30 46 46 46 46 46 46 46 46 46 46 46
Reserves 629 1,927 2,118 2,373 2,637 2,966 3,350 2,347 2,819 3,162 3,550 4,172
0 2 2 2 2 2 2 63 39 41 40 41
318 638 722 840 1,004 926 1,007 810 997 752 593 653
Total Liabilities 977 2,614 2,888 3,261 3,690 3,940 4,405 3,266 3,901 4,001 4,229 4,911
20 944 925 902 950 886 973 894 869 749 713 724
CWIP 3 13 3 15 1 0 1 3 1 8 0 8
Investments 44 43 37 0 0 0 0 0 0 0 0 0
909 1,614 1,923 2,343 2,739 3,054 3,432 2,369 3,030 3,244 3,516 4,180
Total Assets 977 2,614 2,888 3,261 3,690 3,940 4,405 3,266 3,901 4,001 4,229 4,911

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
132 113 345 329 332 98 323 427 667 356 257 660
103 68 -701 -250 -238 35 1,530 -469 -575 -36 54 -71
-1,360 -1 -62 -83 -110 -110 -164 -1,571 -181 -346 -235 -205
Net Cash Flow -1,125 181 -417 -3 -17 23 1,690 -1,613 -88 -26 75 383

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 57 32 26 20 29 30 29 18 20 23 31 31
Inventory Days 148 191 167 148 147 189 198 199 173 175 200 214
Days Payable 156 165 157 178 245 213 197 130 102 91 77 68
Cash Conversion Cycle 49 58 36 -10 -69 6 31 87 91 107 154 177
Working Capital Days 25 7 -9 -46 -57 -15 -7 13 -8 3 31 29
ROCE % 29% 24% 22% 17% 21% 23% 20% 23% 29% 26% 22% 22%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
63.92% 63.92% 63.92% 63.92% 63.92% 63.92% 63.92% 63.92% 63.92% 63.92% 63.92% 63.92%
2.55% 2.55% 2.77% 2.80% 2.81% 2.82% 3.03% 3.32% 3.22% 3.54% 2.74% 2.18%
14.83% 14.88% 14.93% 14.89% 14.89% 15.00% 15.15% 15.32% 15.83% 16.03% 16.80% 17.10%
18.70% 18.65% 18.39% 18.38% 18.37% 18.24% 17.87% 17.42% 17.00% 16.50% 16.54% 16.79%
No. of Shareholders 1,23,4491,22,0281,17,9501,17,1941,15,9881,16,9481,12,4561,09,2141,06,09898,8241,05,0151,08,261

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls